The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 06, 2021
Filed:
Aug. 09, 2019
Applicant:
Janssen Sciences Ireland Unlimited Company, County Cork, IE;
Inventors:
Gang Deng, Shanghai, CN;
Yimin Jiang, Londonberry, NH (US);
Qian Liu, Shanghai, CN;
Chao Liang, Shanghai, CN;
Zhao-Kui Wan, Shanghai, CN;
Wing Shun Cheung, Shanghai, CN;
Zhanling Cheng, Shanghai, CN;
Yanping Xu, Noblesville, IN (US);
Assignee:
Janssen Sciences Ireland Unlimited Company, County Cork, IE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/505 (2006.01); C07D 239/20 (2006.01); C07D 417/14 (2006.01); A61K 45/06 (2006.01); A61K 38/17 (2006.01); A61K 31/675 (2006.01); C07K 16/28 (2006.01); A61K 31/7068 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); A61K 31/675 (2013.01); A61K 31/7068 (2013.01); A61K 38/1793 (2013.01); A61K 45/06 (2013.01); C07K 16/2818 (2013.01);
Abstract
The application describes dihydropyrimidine derivatives which are useful in the treatment or prevention of HBV infection or of HBV-induced diseases, more particularly of HBV chronic infection or of diseases induced by HBV chronic infection, as well as pharmaceutical or medical applications thereof.